Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Isaac Victor

Gynecology Cranford, NJ Medical Doctor

NPI 1073678280 CMS profile 49317

118 South Ave E, Cranford, NJ 07016

Open in the dashboard

General payments

$5,486

451 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Isaac Victor of Cranford, NJ is reported in the CMS Open Payments database as having received $5,486 across 451 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,069 84
2024 General $637 51
2023 General $592 51
2022 General $934 79
2021 General $766 67
2020 General $880 59
2019 General $609 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Isaac Victor
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Isaac Victor were reported at $1,069. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Isaac Victor Gynecology median Middle half National median
2019 $609 $199 $66–$472 $163
2020 $880 $114 $42–$287 $114
2021 $766 $141 $42–$430 $132
2022 $934 $173 $52–$532 $149
2023 $592 $170 $57–$501 $160
2024 $637 $157 $50–$424 $164
2025 $1,069 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Exeltis, USA Inc. $1,688 157 payments
  2. Sumitomo Pharma America, Inc. $599 49 payments
  3. AbbVie, Inc. $400 29 payments
  4. Mayne Pharma Inc. $369 34 payments
  5. Lupin Inc. $365 40 payments
  6. Celularity, Inc. $300 1 payment
  7. Agile Therapeutics, Inc. $194 18 payments
  8. Myovant Sciences Inc. $192 21 payments
  9. CooperSurgical, Inc. $189 14 payments
  10. Organon LLC $175 15 payments
  11. Other $1,016 73 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,128 448 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $300 1 payment
  3. Education $58 2 payments
Products named General payments · program years 2019–2025
  1. SLYND Oral contraceptive $467 45 payments
  2. MYFEMBREE Womens Health $448 38 payments
  3. SLYND Contraceptive $336 26 payments
  4. Nuvessa $300 28 payments
  5. MYFEMBREE Hormone Therapy $297 29 payments
  6. TYBLUME $295 25 payments
  7. LO LOESTRIN FE $289 22 payments
  8. SOLOSEC $231 28 payments
  9. Twirla $194 18 payments
  10. NEXPLANON $175 15 payments
  11. Other $1,734 142 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

451 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record